Catalyst Wire Dossier Catalyst Wire Dossier

Circassia Cat Allergy Peptide Immunotherapy (investigational)

· Circassia Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Circassia Cat Allergy Peptide Immunotherapy (investigational), covering 2014-06-11 to 2014-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis [Phase 1]

See pricing